The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures

Abstract Chen et al. recently related the skin autofluorescence (SAF) of Advanced Glycation End-products to subclinical cardiovascular disease in the 3001 participants from the general population (Rotterdam study), with a particularly close relationship for the 413 subjects with diabetes. Because co...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, Marie-Amélie Barbet-Massin, Amandine Ferriere, Claire Ducos, Kamel Mohammedi, Sami Fawaz, Thierry Couffinhal, Vincent Rigalleau
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-01-01
coleção:	Cardiovascular Diabetology
Assuntos:	Advanced glycation end-products Skin autofluorescence Type 2 diabetes Revascularization
Acesso em linha:	https://doi.org/10.1186/s12933-024-02121-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!